Progen Pharmaceuticals Limited Launches PharmaSynth Manufacturing Unit

Biotechnology firm ProGen Pharmaceuticals has spun-out its manufacturing operations as the new wholly-owned subsidiary PharmaSynth.
MORE ON THIS TOPIC